Search research articles
Contact Us
Filters
Showing results (21-30 of 42) with videos related to
Page
of 5
Sort By:
The Lancet. Respiratory Medicine
|
February 4, 2018
Pound foolish and penny wise-when will dosing of rifampicin be optimised?
Cecile Magis-Escurra, Richard M Anthony, Adri G M van der Zanden, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
April 4, 2022
The case for expanding worldwide access to point of care molecular drug susceptibility testing for isoniazid
Vanessa B Vogensen, Richard M Anthony, Huib A M Kerstjens, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 11, 2017
Bedaquiline Resistance: Its Emergence, Mechanism, and Prevention
Thi Van Anh Nguyen, Richard M Anthony, Anne-Laure Bañuls, et al.
International Journal of Antimicrobial Agents
|
August 18, 2023
Pretomanid resistance: An update on emergence, mechanisms and relevance for clinical practice
Thi Van Anh Nguyen, Quang Huy Nguyen, Tran Nam Tien Nguyen, et al.
Plos One
|
June 15, 2010
Simplified automated image analysis for detection and phenotyping of Mycobacterium tuberculosis on porous supports by monitoring growing microcolonies
Alice L den Hertog, Dennis W Visser, Colin J Ingham, et al.
FEMS Microbiology Letters
|
February 12, 2015
A proportion of mutations fixed in the genomes of in vitro selected isogenic drug-resistant Mycobacterium tuberculosis mutants can be detected as minority variants in the parent culture
Indra Bergval, Francesc Coll, Anja Schuitema, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
March 22, 2024
Characteristic SNPs defining the major multidrug-resistant <i>Mycobacterium tuberculosis</i> clusters identified by EuSeqMyTB to support routine surveillance, EU/EEA, 2017 to 2019
Albert J de Neeling, Elisa Tagliani, Csaba Ködmön, et al.
Expert Review of Anti-Infective Therapy
|
October 21, 2016
Individualizing management of extensively drug-resistant tuberculosis: diagnostics, treatment, and biomarkers
Jan-Willem C Alffenaar, Onno W Akkerman, Richard M Anthony, et al.
Plos One
|
June 18, 2025
Verification of emerging genomic mutations in Mycobacterium tuberculosis allows transmission chains to be distinguished in an epidemiological typing cluster extending over thirty years
Rina de Zwaan, Gerard de Vries, Ella Ubbelohde, et al.
BMC Infectious Diseases
|
July 13, 2017
Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia
Sarah Sengstake, Indra L Bergval, Anja R Schuitema, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 42) with videos related to
Sort By:
Page
of 5
The Lancet. Respiratory Medicine
|
February 4, 2018
Pound foolish and penny wise-when will dosing of rifampicin be optimised?
Cecile Magis-Escurra, Richard M Anthony, Adri G M van der Zanden, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
April 4, 2022
The case for expanding worldwide access to point of care molecular drug susceptibility testing for isoniazid
Vanessa B Vogensen, Richard M Anthony, Huib A M Kerstjens, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 11, 2017
Bedaquiline Resistance: Its Emergence, Mechanism, and Prevention
Thi Van Anh Nguyen, Richard M Anthony, Anne-Laure Bañuls, et al.
International Journal of Antimicrobial Agents
|
August 18, 2023
Pretomanid resistance: An update on emergence, mechanisms and relevance for clinical practice
Thi Van Anh Nguyen, Quang Huy Nguyen, Tran Nam Tien Nguyen, et al.
Plos One
|
June 15, 2010
Simplified automated image analysis for detection and phenotyping of Mycobacterium tuberculosis on porous supports by monitoring growing microcolonies
Alice L den Hertog, Dennis W Visser, Colin J Ingham, et al.
FEMS Microbiology Letters
|
February 12, 2015
A proportion of mutations fixed in the genomes of in vitro selected isogenic drug-resistant Mycobacterium tuberculosis mutants can be detected as minority variants in the parent culture
Indra Bergval, Francesc Coll, Anja Schuitema, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
March 22, 2024
Characteristic SNPs defining the major multidrug-resistant <i>Mycobacterium tuberculosis</i> clusters identified by EuSeqMyTB to support routine surveillance, EU/EEA, 2017 to 2019
Albert J de Neeling, Elisa Tagliani, Csaba Ködmön, et al.
Expert Review of Anti-Infective Therapy
|
October 21, 2016
Individualizing management of extensively drug-resistant tuberculosis: diagnostics, treatment, and biomarkers
Jan-Willem C Alffenaar, Onno W Akkerman, Richard M Anthony, et al.
Plos One
|
June 18, 2025
Verification of emerging genomic mutations in Mycobacterium tuberculosis allows transmission chains to be distinguished in an epidemiological typing cluster extending over thirty years
Rina de Zwaan, Gerard de Vries, Ella Ubbelohde, et al.
BMC Infectious Diseases
|
July 13, 2017
Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia
Sarah Sengstake, Indra L Bergval, Anja R Schuitema, et al.
Page
of 5